Am. J. Respir. Crit. Care Med., Volume 162, Number 3, September 2000, 837-843

Rotation and Restricted Use of Antibiotics in a Medical Intensive Care Unit
Impact on the Incidence of Ventilator-associated Pneumonia Caused by Antibiotic-resistant Gram-negative Bacteria

DIDIER GRUSON, GILLES HILBERT, FREDERIC VARGAS, RUDDY VALENTINO, CECILE BEBEAR, ANNIE ALLERY, CHRISTIANE BEBEAR, GEORGES GBIKPI-BENISSAN, and JEAN-PIERRE CARDINAUD

Pulmonary and Critical Care Division and Department of Bacteriology, University Hospital of Bordeaux, Bordeaux, France

To test the hypothesis that a new program of antibiotic strategy control can minimize the incidence of ventilator-associated pneumonia (VAP) caused by potentially antibiotic-resistant microorganisms, we performed a prospective before-after study in 3,455 patients admitted to a single intensive care unit over a 4-yr period. Regarding the bacterial ecology and the increasing antimicrobial resistance in our medical intensive care unit (MICU), we decided to vary our choice of empiric and therapeutic antibiotic treatment, with a supervised rotation, and a restricted use of ceftazidime and ciprofloxacin, which were widely prescribed before this scheduled change. For all patients, VAP was diagnosed based on the results of quantitative culture of bronchoalveolar lavage specimens ( 10⁴ cfu/ml). We studied 1,044 and 1,022 patients requiring more than 48 h of mechanical ventilation (MV), respectively, in the before-period (2 yr: 1995-1996) and the after-period (2 yr: 1997-1998). We observed a decrease from 231 consecutive episodes of VAP in the before-period to 161 episodes of VAP in the after-period (p < 0.01), particularly for VAP occurring before 7 d of MV. The total number of potentially antibiotic-resistant gram-negative bacilli responsible for VAP such as Pseudomonas aeruginosa, Burkholderia cepacia, Steno-trophomonas maltophilia, and Acinetobacter baumanii decreased from 140 to 79 isolated bacilli. The susceptibilities of these bacteria to the antibiotics regimen increased significantly, especially for P. aeruginosa and B. cepacia. The percentage of methicillin-sensitive Staphylococcus aureus increased significantly from 40% to 60% of S. aureus responsible for VAP. These results suggest that a new strategy of antibiotics use could be an efficient means to reduce the incidence of VAP caused by antibiotic-resistant bacteria. Nevertheless, further studies are needed to validate these data.

This article has been cited by other articles:

				R. Gupta and K. A. Wargo An Update on the Management of Nosocomial Pneumonia Journal of Pharmacy Practice, October 1, 2008; 21(5): 380 - 389. [Abstract] [PDF]

				L. R. Merz, D. K. Warren, M. H. Kollef, S. K. Fridkin, and V. J. Fraser The Impact of an Antibiotic Cycling Program on Empirical Therapy for Gram-Negative Infections Chest, December 1, 2006; 130(6): 1672 - 1678. [Abstract] [Full Text] [PDF]

				S. M. Koenig and J. D. Truwit Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention Clin. Microbiol. Rev., October 1, 2006; 19(4): 637 - 657. [Abstract] [Full Text] [PDF]

				M. H. Scheetz, K. M. Hurt, G. A. Noskin, and C. M. Oliphant Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens. Am. J. Health Syst. Pharm., July 15, 2006; 63(14): 1346 - 1360. [Abstract] [Full Text] [PDF]

				A. Sandiumenge, E. Diaz, A. Rodriguez, L. Vidaur, L. Canadell, M. Olona, M. Rue, and J. Rello Impact of diversity of antibiotic use on the development of antimicrobial resistance J. Antimicrob. Chemother., June 1, 2006; 57(6): 1197 - 1204. [Abstract] [Full Text] [PDF]

				C. G. Gemmell, D. I. Edwards, A. P. Fraise, F. K. Gould, G. L. Ridgway, R. E. Warren, and on behalf of the Joint Working Party of the Britis Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK J. Antimicrob. Chemother., April 1, 2006; 57(4): 589 - 608. [Abstract] [Full Text] [PDF]

				H. J. van Loon, M. R. Vriens, A. C. Fluit, A. Troelstra, C. van der Werken, J. Verhoef, and M. J. M. Bonten Antibiotic Rotation and Development of Gram-Negative Antibiotic Resistance Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 480 - 487. [Abstract] [Full Text] [PDF]

				Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416. [Full Text] [PDF]

				E. M. Brown and D. Nathwani Antibiotic cycling or rotation: a systematic review of the evidence of efficacy J. Antimicrob. Chemother., January 1, 2005; 55(1): 6 - 9. [Abstract] [Full Text] [PDF]

				R. G. Masterton Antibiotic cycling: more than it might seem? J. Antimicrob. Chemother., January 1, 2005; 55(1): 1 - 5. [Abstract] [Full Text] [PDF]

				C. T. Bergstrom, M. Lo, and M. Lipsitch From The Cover: Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals PNAS, September 7, 2004; 101(36): 13285 - 13290. [Abstract] [Full Text] [PDF]

				M. Ioanas, M. Cavalcanti, M. Ferrer, M. Valencia, C. Agusti, J. Puig de la Bellacasa, and A. Torres Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines Eur. Respir. J., December 1, 2003; 22(6): 876 - 882. [Abstract] [Full Text] [PDF]

				S. Osmon, D. Warren, S. M. Seiler, W. Shannon, V. J. Fraser, and M. H. Kollef The Influence of Infection on Hospital Mortality for Patients Requiring > 48 h of Intensive Care Chest, September 1, 2003; 124(3): 1021 - 1029. [Abstract] [Full Text] [PDF]

				R. M. Mehta and M. S. Niederman Nosocomial Pneumonia in the Intensive Care Unit: Controversies and Dilemmas J Intensive Care Med, July 1, 2003; 18(4): 175 - 188. [Abstract] [PDF]

				G. Hoffken and M. S. Niederman Nosocomial Pneumonia: The Importance of a De-escalating Strategy for Antibiotic Treatment of Pneumonia in the ICU Chest, December 1, 2002; 122(6): 2183 - 2196. [Abstract] [Full Text] [PDF]

				P. Toltzis, M. J. Dul, C. Hoyen, A. Salvator, M. Walsh, L. Zetts, and H. Toltzis The Effect of Antibiotic Rotation on Colonization With Antibiotic-Resistant Bacilli in a Neonatal Intensive Care Unit Pediatrics, October 1, 2002; 110(4): 707 - 711. [Abstract] [Full Text] [PDF]

				P. M. Lepper, E. Grusa, H. Reichl, J. Hogel, and M. Trautmann Consumption of Imipenem Correlates with {beta}-Lactam Resistance in Pseudomonas aeruginosa Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2920 - 2925. [Abstract] [Full Text] [PDF]

				J. Chastre and J.-Y. Fagon Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903. [Abstract] [Full Text] [PDF]

				H. Giamarellou Prescribing guidelines for severe Pseudomonas infections J. Antimicrob. Chemother., February 1, 2002; 49(2): 229 - 233. [Full Text] [PDF]

				P. Eggimann and D. Pittet Infection Control in the ICU Chest, December 1, 2001; 120(6): 2059 - 2093. [Abstract] [Full Text] [PDF]

				M. J. Tobin Taxonomy of AJRCCM, a New Series, and a Medley of Metaphors Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1333 - 1335. [Full Text] [PDF]

				M. J. TOBIN Critical Care Medicine in AJRCCM 2000 Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1347 - 1361. [Full Text] [PDF]

				Members of the Task Force:, E. Bouza, C. Brun-Buisson, J. Chastre, S. Ewig, J-Y. Fagon, C.H. Marquette, P. Munoz, M.S. Niederman, L. Papazian, et al. Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet Eur. Respir. J., May 1, 2001; 17(5): 1034 - 1045. [Full Text] [PDF]

				M. H. Kollef and V. J. Fraser Antibiotic Resistance in the Intensive Care Unit Ann Intern Med, February 20, 2001; 134(4): 298 - 314. [Abstract] [Full Text] [PDF]